Trial Profile
A Study to Compare the Efficacy of Sci-B-Vac versus Engerix-B Active Vaccines in Preventing Vertical Hepatitis B Virus (HBV) Transmission Within Neonates at High Risk
Status:
Active, no longer recruiting
Phase of Trial:
Phase II
Latest Information Update: 19 Dec 2015
Price :
$35
*
At a glance
- Drugs Hepatitis B vaccine recombinant (Primary)
- Indications Hepatitis B
- Focus Therapeutic Use
- 19 Dec 2015 New trial record